A growing body of evidence shows that lung cancer cells exploit several mechanisms for immune evasion, mainly by the production of immunosuppressive cytokines and the expression of T cell-activation-inhibiting molecules, most notably CTLA-4 (cytotoxic T lymphocyte-associated 4) and PD1/PD-L1 [8]. This evidence concerns the gene CD274 and lung carcinoma.